Table 2.
Linear mixed regression analysis with random intercept were performed to assess the effect of sex hormones on Pheno Age, GrimAge, DNAm-based PAI1, and DNAm-based leptin. Sex hormones were standardized and winsorized (highest and lowest 1%) by study. The analyses were performed stratified by sex, and adjusted for age, body mass index (BMI), alcohol intake, smoking packyears, physical activity, the time between visits, cohort study, and blood cell composition based on DNAm. Among women, we also adjusted for time since menopause.
Men | Females | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Outcome | Sex Hormones | Est. | 95% LL |
95% UL |
P | BH-P | Est. | 95% LL |
95% UL |
P | BH-P |
Pheno AA | E1 | 0.26 | −0.09 | 0.61 | 0.14 | 0.31 | 0.06 | −0.42 | 0.54 | 0.79 | 0.96 |
E2 | 0.13 | −0.15 | 0.40 | 0.37 | 0.67 | 0.05 | −0.32 | 0.41 | 0.81 | 0.96 | |
SHBG | −0.11 | −0.41 | 0.19 | 0.47 | 0.67 | −0.40 | −0.75 | −0.04 | 0.03 | 0.22 | |
TotT | −0.35 | −0.64 | −0.06 | 0.02 | 0.08 | 0.11 | −0.23 | 0.44 | 0.54 | 0.92 | |
TE ratio | −0.41 | −0.70 | −0.12 | 0.01 | 0.04 | −0.12 | −0.48 | 0.23 | 0.49 | 0.92 | |
DHEAS | −0.02 | −0.62 | 0.57 | 0.94 | 0.98 | 0.38 | −0.12 | 0.87 | 0.14 | 0.47 | |
Grim AA | E1 | 0.19 | −0.02 | 0.39 | 0.07 | 0.22 | 0.03 | −0.22 | 0.29 | 0.80 | 0.96 |
E2 | −0.04 | −0.21 | 0.12 | 0.59 | 0.71 | 0.04 | −0.15 | 0.23 | 0.66 | 0.96 | |
SHBG | 0.05 | −0.13 | 0.22 | 0.59 | 0.71 | −0.10 | −0.29 | 0.08 | 0.28 | 0.76 | |
TotT | −0.22 | −0.39 | −0.05 | 0.01 | 0.06 | 0.00 | −0.18 | 0.18 | 0.99 | 0.99 | |
TE ratio | −0.16 | −0.33 | 0.01 | 0.07 | 0.22 | −0.14 | −0.32 | 0.05 | 0.16 | 0.48 | |
DHEAS | 0.28 | −0.08 | 0.64 | 0.12 | 0.30 | 0.09 | −0.16 | 0.34 | 0.50 | 0.92 | |
DNAm PAI1 | E1 | 61 | −100 | 222 | 0.46 | 0.67 | −67 | −270 | 136 | 0.52 | 0.92 |
E2 | −103 | −230 | 24 | 0.11 | 0.30 | 139 | −22 | 299 | 0.09 | 0.37 | |
SHBG | −478 | −614 | −343 | 1E-11 | 1E-10 | −434 | −589 | −279 | 1E-07 | 2E-06 | |
TotT | −481 | −613 | −349 | 2E-12 | 6E-11 | −134 | −284 | 15 | 0.08 | 0.37 | |
TE ratio | −351 | −486 | −217 | 4E-07 | 3E-06 | −197 | −356 | −39 | 0.02 | 0.18 | |
DHEAS | 68 | −200 | 335 | 0.62 | 0.71 | −21 | −264 | 222 | 0.86 | 0.96 | |
DNAm LEPTIN | E1 | 0 | −90 | 89 | 1.00 | 1.00 | 13 | −162 | 187 | 0.89 | 0.96 |
E2 | −28 | −101 | 45 | 0.44 | 0.67 | 28 | −106 | 163 | 0.68 | 0.96 | |
SHBG | −30 | −109 | 50 | 0.46 | 0.67 | −140 | −271 | −10 | 0.04 | 0.22 | |
TotT | −26 | −103 | 52 | 0.52 | 0.69 | 42 | −82 | 166 | 0.50 | 0.92 | |
TE ratio | 18 | −60 | 95 | 0.66 | 0.72 | −26 | −159 | 107 | 0.70 | 0.96 | |
DHEAS | −75 | −253 | 104 | 0.41 | 0.67 | 9 | −174 | 193 | 0.92 | 0.96 |
Abbreviations: Est: Effect estimate; LL: Lower Limit; UL: Upper Limit; P: P-value; BH-P: Benjamini-Hochberg adjusted P-value; AA: Age Acceleration; DNAm: DNA-methylation; E1: total estrone; E2: total estradiol; SHBG: Sex Hormone Binding Globulin; TotT: total testosterone; TE ratio: Total testosterone divided by total estradiol concentration